V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008952 | 190007462 | 1.75 | 167 | null | 2021-03-04 | 2021-03-11 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101825577 |
| 190008969 | 190007463 | 1.77 | 58.5 | Palliative (P) | 2021-06-06 | 2021-06-29 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101317787 |
| 190008992 | 190007464 | 1.59 | 61 | null | 2020-05-13 | 2020-05-15 | null | 02 | Y | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100088471 |
| 190008994 | 190007465 | 0 | 45.3 | Adjuvant (A) | 2022-04-30 | 2022-05-21 | EURAMOS TRIAL | 02 | null | CARBOPLATIN + GEMCITABINE | 101583290 |
| 190009001 | 190007466 | 1.78 | 67.1 | null | 2019-12-11 | 2020-01-08 | OST Euramos 1 Closed Trial - M | 01 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 100546701 |
| 190009011 | 190007467 | 1.68 | 98.1 | Palliative (P) | 2020-01-01 | 2020-03-19 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CAPECITABINE + IRINOTECAN | 100810051 |
| 190009022 | 190007468 | 1.75 | 61 | null | null | 2022-04-22 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | CAPECITABINE + OXALIPLATIN | 100629178 |
| 190009035 | 190007469 | 0 | 31.9 | null | null | 2016-04-16 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | null | CISPLATIN + RT | 100827071 |
| 190009044 | 190007470 | 0 | 12.7 | null | 2016-11-19 | 2017-03-25 | STS Rhabdo RMS 2005 2nd Topo Cyclo | 01 | N | CAPECITABINE | 101825501 |
| 190009051 | 190007471 | 1.88 | 90.5 | Curative (C) | 2020-10-19 | 2020-11-16 | Cytarabine intrathecal | null | null | CAPECITABINE + IRINOTECAN | 100985989 |
| 190009057 | 190007472 | 1.76 | 64 | null | 2019-04-19 | 2019-04-24 | Oxaliplatin + Modified de Gramont | 02 | N | CISPLATIN + GEMCITABINE | 100942308 |
| 190009138 | 190007473 | null | null | null | null | 2020-01-19 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100191597 |
| 190009152 | 190007474 | 1.77 | 67.8 | Neo-adjuvant (N) | 2021-10-15 | 2021-10-15 | Ifosfamide | 01 | null | CISPLATIN + GEMCITABINE | 100349515 |
| 190009200 | 190007476 | 0 | 42.5 | Palliative (P) | 2019-06-13 | 2019-06-18 | EW EuroEwing 2012 Arm A VAI | 02 | N | CARBOPLATIN + GEMCITABINE | 100160406 |
| 190009215 | 190007477 | 0 | 24 | null | 2019-03-19 | 2019-03-23 | Ifosfamide | null | null | NIVOLUMAB | 100645235 |
| 190009227 | 190007478 | null | 96 | Palliative (P) | 2018-09-01 | 2018-09-09 | Capecitabine (21 day) + Irinotecan | 02 | N | PACLITAXEL | 101626008 |
| 190009232 | 190007479 | 1.66 | 56.8 | null | 2021-01-29 | 2021-02-13 | OST Euramos 1 Closed Trial - M | 2 | N | CISPLATIN + GEMCITABINE | 100547903 |
| 190009242 | 190007480 | 1.67 | 73.7 | null | null | 2021-07-20 | Trial Unspecified | 02 | null | FLUOROURACIL + OXALIPLATIN | 100579455 |
| 190009262 | 190007481 | 1.72 | 83.8 | 03 | 2020-01-17 | 2020-01-29 | EW EuroEwing 2012 Arm A/B BuMEL | null | null | CARBOPLATIN | 100285155 |
| 190009326 | 190007482 | 0 | 18.9 | null | 2017-04-02 | 2017-08-09 | Docetaxel | 02 | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100858772 |
| 190009329 | 190007483 | 1.82 | 25.7 | null | 2019-12-15 | 2019-12-15 | Cyclophosphamide + Vincristine | N | Y | ECX | 100062057 |
| 190009359 | 190007484 | 1.53 | 65.6 | Neo-adjuvant (N) | 2021-08-03 | 2021-12-06 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100505515 |
| 190009365 | 190007485 | 1.64 | 47.9 | 03 | 2015-09-13 | 2015-10-05 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101285967 |
| 190009370 | 190007486 | 1.72 | 84.8 | null | 2018-01-07 | 2018-08-25 | CISPLATIN + GEMCITABINE | Y | N | CISPLATIN + FLUOROURACIL | 100310839 |
| 190009375 | 190007487 | 1.69 | 65.2 | Curative (C) | 2021-10-02 | 2021-11-01 | EW EuroEwing 2012 Arm B VDC | 02 | N | IPILIMUMAB | 101571506 |
| 190009383 | 190007488 | 1.79 | 70.25 | Curative (C) | 2021-09-01 | 2021-11-17 | EW EuroEwing 2012 Arm A VAI | 02 | N | CISPLATIN + GEMCITABINE | 101263645 |
| 190009391 | 190007489 | 1.58 | 28.6 | Palliative (P) | 2021-09-03 | 2021-09-24 | Carboplatin + Etoposide IV 3 day | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100856565 |
| 190009394 | 190007490 | 1.86 | 73 | Palliative (P) | 2019-09-23 | 2020-03-30 | Cisplatin | 01 | N | CISPLATIN | 101428911 |
| 190009396 | 190007491 | 1.77 | 67.6 | Palliative (P) | 2019-07-03 | 2019-07-30 | Avelumab | 02 | N | CARBOPLATIN + ETOPOSIDE | 101470043 |
| 190009397 | 190007492 | 1.84 | 24.5 | Palliative (P) | 2016-10-27 | 2017-01-13 | BEAM | null | null | ABIRATERONE | 100097636 |
| 190009405 | 190007493 | 0 | 0 | Palliative (P) | 2020-06-21 | 2020-06-21 | GemCarbo Days 1+8 | null | null | PACLITAXEL | 101728198 |
| 190009415 | 190007494 | 1.79 | 73.3 | Palliative (P) | 2019-08-29 | 2019-09-15 | Docetaxel 75mg/m2 (21 day) | null | N | CARBOPLATIN | 100285785 |
| 190009416 | 190007495 | 1.78 | 56 | null | 2019-04-23 | 2019-05-06 | CABOZANTINIB | null | null | NIVOLUMAB | 101804731 |
| 190009428 | 190007496 | 1.84 | 62.2 | Neo-adjuvant (N) | 2021-11-01 | 2022-05-26 | Doxorubicin + Olaratumab | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101159450 |
| 190009436 | 190007497 | 1.57 | 55 | Palliative (P) | 2019-03-04 | 2019-08-19 | Capecitabine + Oxaliplatin 21day | 02 | null | CISPLATIN + GEMCITABINE | 101506781 |
| 190009440 | 190007498 | 1.84 | 78.8 | Palliative (P) | 2018-12-02 | 2019-01-03 | null | 02 | N | GEMCITABINE | 100102281 |
| 190009449 | 190007499 | 1.7 | 63 | null | 2021-01-08 | 2021-03-03 | EW EuroEwing 2012 Arm A VIDE | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 101848028 |
| 190009459 | 190007500 | 1.7 | 61.8 | null | 2020-03-20 | 2020-06-30 | OST Euramos 1 Closed Trial - M | 02 | null | CARBOPLATIN + ETOPOSIDE | 101373999 |
| 190009469 | 190007501 | 1.59 | 59.6 | Curative (C) | 2018-06-29 | 2018-10-28 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 02 | N | CISPLATIN + GEMCITABINE | 100346219 |
| 190009475 | 190007502 | 1.68 | 49.8 | Palliative (P) | 2016-03-09 | 2016-09-13 | METHOTREXATE | null | null | METHOTREXATE | 101755166 |
| 190009505 | 190007503 | 1.76 | 55 | Curative (C) | 2018-05-18 | 2018-11-28 | Methotrexate High Dose (3g/m2) | Y | N | METHOTREXATE | 100154257 |
| 190009516 | 190007504 | 1.49 | 62 | null | null | 2021-10-19 | MAP | null | null | TIVOZANIB | 101835370 |
| 190009522 | 190007505 | 0 | 54 | Neo-adjuvant (N) | 2020-07-25 | 2020-08-01 | Oxaliplatin + Modified de Gramont | 02 | N | CARBOPLATIN + ETOPOSIDE | 101045682 |
| 190009548 | 190007506 | 1.74 | 82.6 | Palliative (P) | 2016-11-23 | 2016-12-09 | Docetaxel 100mg/m2 (21 day) | N | Y | EURAMOS TRIAL | 100759437 |
| 190009576 | 190007507 | 0 | 57.4 | Neo-adjuvant (N) | 2018-06-09 | 2018-06-25 | NB HRNBL | 02 | N | IFOSFAMIDE | 101692741 |
| 190009580 | 190007508 | 1.9 | 76.1 | Palliative (P) | 2019-02-26 | 2019-03-02 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101149101 |
| 190009586 | 190007509 | 0 | 41 | Palliative (P) | 2020-04-09 | 2020-05-06 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B VDC/IE | 100381543 |
| 190009605 | 190007510 | 1.5 | 77.95 | Adjuvant (A) | 2016-07-05 | 2016-12-05 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN + METHOTREXATE | 101617699 |
| 190009610 | 190007511 | 0 | 45.3 | null | 2018-12-15 | 2019-04-06 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100120986 |
| 190009619 | 190007512 | 0 | 69.1 | Palliative (P) | 2020-04-26 | 2020-05-27 | CNS ATRT Carboplatin/Thiotepa + GCSF | Y | N | METHOTREXATE HIGH DOSE | 100675442 |